AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal ...
AIV001 is currently in development for evaluation in Superficial and Nodular Superficial Basal Cell Carcinoma (sBCC and nBCC)COSA MESA, Calif., ...